Relationship between HAVOC score and new-onset atrial fibrillation in patients with ST elevation myocardial infarction [0.03%]
HAVOC评分与ST段抬高型心肌梗死患者新发房颤的关系
Emrah Bayam,Macit Kalçık,Ersin Yıldırım et al.
Emrah Bayam et al.
Background: Atrial fibrillation (AF) is a common electrical complication in patients with acute myocardial infarction. The HAVOC score was originally proposed as a clinical tool for predicting AF in patients with cryptoge...
Johann Bauersachs,Ralf Zahn
Johann Bauersachs
Editorial
Herz. 2026 Jun;51(3):161-162. DOI:10.1007/s00059-026-05376-8 2026
Tobias Friedrich Ruf,Theresa Ann-Marie Gößler,Philipp Lurz
Tobias Friedrich Ruf
Transcatheter mitral valve interventions have seen a tremendous and constant increase in use over the past decade. Treatment is mainly aimed at mitral regurgitation (MR), the most common valve disease in industrialized countries. While tran...
Review
Herz. 2026 May 5. DOI:10.1007/s00059-026-05377-7 2026
Research hotspots and emerging trends of exosomes in myocardial infarction: a bibliometric-based visual analysis [0.03%]
基于文献计量学的可视化分析探究外泌体心肌梗死研究热点及新兴趋势
Runfang Deng,Weiju Liao,Lingling Wu et al.
Runfang Deng et al.
Objective: The aim of this study was to summarize the current research status and application of exosomes in the treatment of myocardial infarction (MI) through bibliometric analysis and to provide insights and suggestion...
Advanced interatrial block independently predicts appropriate and inappropriate ICD therapies in hypertrophic cardiomyopathy [0.03%]
房室间阻滞可独立预测肥厚型心肌病患者适当的和不适当的ICD治疗
Nizamettin Selçuk Yelgeç,Can Baba Arın,Ayşegül Aygün et al.
Nizamettin Selçuk Yelgeç et al.
Background: Implantable cardioverter-defibrillators (ICDs) reduce the risk of sudden cardiac death in hypertrophic cardiomyopathy (HCM); however, both appropriate and inappropriate shocks carry important clinical implicat...
[Cardiovascular pharmacotherapy in the era of RNA-based precision medicine] [0.03%]
基于RNA的精准医学时代的心血管药物治疗
Anselm A Derda,Anna Hohneck
Anselm A Derda
In the pharmacotherapy of heart failure with reduced ejection fraction (HFrEF) in addition to the "fantastic four", a potential fifth pillar is emerging with low-dose digitoxin, while finerenone broadens the spectrum of mineralocorticoid re...
[Cardiovascular medicine 2026-overcoming boundaries together, setting standards] [0.03%]
[心血管医学2026——携手克服界限，共同树立标准]
Stephan Willems
Stephan Willems
Editorial
Herz. 2026 Mar;51(2):79-80. DOI:10.1007/s00059-026-05370-0 2026
Contemporary insights and evolving clinical pathways in transcatheter tricuspid valve replacement [0.03%]
经导管三尖瓣置换的最新见解和临床路径演变
J G da Rocha E Silva,L Stolz,H Kempton et al.
J G da Rocha E Silva et al.
Transcatheter tricuspid valve replacement (TTVR) has emerged as an important therapeutic option for patients with severe tricuspid regurgitation (TR), particularly those with high surgical risk and complex anatomy. This review summarizes th...
Review
Herz. 2026 Mar 3. DOI:10.1007/s00059-026-05371-z 2026
Dominik Berliner,Sven Schallhorn,Johann Bauersachs
Dominik Berliner
Severe tricuspid regurgitation (TR) is a common right-sided valvular disease associated with a substantially increased risk of morbidity, hospitalization, and mortality. Transcatheter tricuspid edge-to-edge repair (T-TEER) is a minimally in...
Erratum to: Atherogenic index as an associative marker for coronary artery disease [0.03%]
冠心病相关标志物动脉粥样硬化指数的影响因素及其与颈动脉内膜中层厚度的关系的更正
Basavaraj Utagi,Dilip Johny,Aditya Ojha et al.
Basavaraj Utagi et al.
Published Erratum
Herz. 2026 Feb 26. DOI:10.1007/s00059-026-05374-w 2026